Showing results (1151-1160 of 1,368) with videos related to

Sort By:
Pageof 137
Epigenetics|July 22, 2011
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesotheliomaHeather H Nelson, Lindsay M Almquist, Jessica L LaRocca, et al.
Cancer Epidemiology|May 20, 2018
Toenail selenium, genetic variation in selenoenzymes and risk and outcome in gliomaNoah C Peeri, Jordan H Creed, Gabriella M Anic, et al.
Hematological Oncology|April 11, 2012
Alterations of negative regulators of cytokine signalling in immunodeficiency-related non-Hodgkin lymphomaDaniela Capello, Annunziata Gloghini, Gianluca Baldanzi, et al.
Cancer Cytopathology|July 31, 2023
Diagnostic role of FNA cytology in the evaluation of cervical lymph nodes in thyroid cancers: Combined evaluation of thyroglobulin in eluate from FNA cytologyPietro Tralongo, Carmine Bruno, Federica Policardo, et al.
Leukemia & Lymphoma|May 8, 2013
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietinMaria Chiara Tisi, Valentina Bozzoli, Manuela Giachelia, et al.
Hepatology (Baltimore, Md.)|October 12, 2013
G-protein-coupled receptor 30/adenylyl cyclase/protein kinase A pathway is involved in estradiol 17ß-D-glucuronide-induced cholestasisAndrés E Zucchetti, Ismael R Barosso, Andrea C Boaglio, et al.
Cell Death and Differentiation|November 24, 2012
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomasC Ciceroni, M Bonelli, E Mastrantoni, et al.
Scientific Reports|July 28, 2019
Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of gliomaJordan H Creed, Noah C Peeri, Gabriella M Anic, et al.
Blood Cancer Journal|April 17, 2025
Long-term outcomes and clinical phenotypes associated with best response to low dose alemtuzumab in cutaneous T-cell lymphomaCecilia Larocca, Ai-Tram N Bui, John T O'Malley, et al.
Cancer Medicine|January 14, 2016
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphomaAnnarosa Cuccaro, Salvatore Annunziata, Elisa Cupelli, et al.
Pageof 137